Related Experiment Video
Updated: Mar 1, 2026
05:25
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
3.0K
Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and Endocannabinoid System in Two Human Cancer
Repossi Gastón1, Pasqualini María Eugenia2, Undurti N Das3
1Biología Celular, Histología y Embriología, Facultad de Ciencias Médicas, Universidad Nacional Córdoba, Argentina; Cátedra de Histología y Embriología, Universidad Nacional de La Rioja, La Rioja, Argentina; INICSA, CONICET-UNC, Córdoba, Argentina.
Archives of Medical Research
|June 5, 2017
Summary
Dietary fatty acids differentially impact tumor cell growth by interacting with the endocannabinoid system. Essential fatty acids (EFAs) and non-EFAs influence cancer cell proliferation and endocannabinoid levels, suggesting a targeted therapeutic potential.
Area of Science:
- Lipid metabolism and cancer biology
- Endocannabinoid system signaling
- Nutritional oncology
Background:
- Dietary polyunsaturated fatty acids (PUFAs) are implicated in cancer development, but mechanisms remain unclear.
- Endocannabinoids, lipid metabolites, possess tumor growth-modulatory properties.
- Investigating the interplay between dietary lipids and the endocannabinoid system in cancer is crucial.
Purpose of the Study:
- To examine the effects of essential fatty acids (EFAs) and non-EFAs on tumor cell growth.
- To determine how fatty acid supplementation alters endocannabinoid content in cancer cells.
- To elucidate the role of fatty acids in modulating cancer cell proliferation via the endocannabinoid system.
Main Methods:
- Human glioblastoma (T98G) and breast cancer (MCF7) cell lines were cultured.
- Cells were supplemented with omega-6 and omega-3 (EFAs), saturated, and monounsaturated fatty acids (non-EFAs).
- Assays included MTT for proliferation, HPLC for anandamide (AEA), GLC for fatty acid profiles, Western blot for CB1 receptor, and spectrophotometry for FAAH activity.
Main Results:
- Fatty acid profiles confirmed successful lipid incorporation.
- Arachidonic acid (EFA ω-6) increased AEA and inhibited T98G growth; palmitic acid (non-EFA) enhanced T98G proliferation.
- Eicosapentaenoic acid (EFA ω-3) reduced MCF7 proliferation; oleic acid (non-EFA) enhanced it. CB1 receptor expression was higher in T98G cells.
Conclusions:
- Tumor cell growth is differentially modulated by various fatty acids.
- This modulation is partly mediated by interactions with the endocannabinoid system.
- Targeting fatty acid composition may offer novel strategies for cancer therapy.
Related Concept Videos
01:19Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
864
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
864
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K